Search clinical trials for: Control Gel

Total 67337 results

Ondokuz Mayıs University

Completed

Aesthetic Efficacy of Resin Infiltration Using Different Conditioning Methods: 24-Month Results

White Spot Lesion

Turkey
Bausch Health Americas, Inc.

Completed

Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris

Acne Vulgaris

United States, Canada
Bausch Health Americas, Inc.

Completed

Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris

Acne Vulgaris

United States, Canada
Dermavant Sciences GmbH

Completed

Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo

Vitiligo

United States
LEO Pharma

Completed

Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up

Actinic Keratosis

United States
Maruho Co., Ltd.
Leiden University Medical Center

Completed

Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With External Genital Warts

Condylomata Acuminata (External)

Netherlands
Mahidol University

Completed

Effect of Holly Mangrove Shower Gel in Atopic Dermatitis Patients

Atopic Dermatitis

Thailand
Peplin

Completed

A Study to Evaluate the Pharmacokinetics of PEP005 (Ingenol Mebutate) Gel, 0.05%, When Applied in a Maximal Use Setting to the Dorsal Aspect of the Forearm in Patients With Actinic Keratosis

Actinic Keratosis

United States
G&E Herbal Biotechnology Co., LTD

Completed

Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs)

Genital Warts | Condylomata Acuminata | Condyloma Acuminata | Venereal Warts

Taiwan
Dokuz Eylul University

Completed

Comparison Between the I-gel and the LMA-Unique

Anaesthesia

Turkey
Energenesis Biomedical Co., Ltd.

Recruiting

A Study to Evaluate ENERGI-F703 GEL in Venous Leg Ulcer

Venous Leg Ulcer

Taiwan
Universidad de Murcia

Unknown

Clinical Study New Gel for Xerostomia (XEROSTOMIA)

XEROSTOMIA

Spain
Lakewood-Amedex Inc
PrimeVigilance; Professional Education and Research Institute

Terminated

Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer

Chronic Diabetic Foot Ulcers

United States
G&E Herbal Biotechnology Co., LTD

Suspended

Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients

Common Wart
Population Council

Completed

Safety, Pharmacokinetics and Acceptability of PC-1005 for Vaginal Use

HIV

United States
NovaBay Pharmaceuticals, Inc.

Completed

Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo

Impetigo

United States, South Africa
Glia, LLC
ORA, Inc.

Completed

Treatment Safety and Efficacy of Pro-ocular™ 1% for Chronic Ocular Graft Following Allogeneic HSCT.

Chronic Ocular Graft-versus-host Disease

United States
Izun Pharma Ltd

Completed

Efficacy Study of IZN-6D4 Gel for the Treatment of Diabetic Foot Ulcers

Diabetic Foot Ulcer

Israel
Galderma R&D

Completed

Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema of Rosacea

Rosacea

Russian Federation, France, Sweden
Ralexar Therapeutics, Inc.

Unknown

Study in Subjects With Moderate Atopic Dermatitis

Atopic Dermatitis Eczema

United States, Canada
Galderma R&D

Withdrawn

Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Persistent Facial Erythema

Erythema
Indiana University School of Medicine

Completed

Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial

Bacterial Vaginosis

United States
Hovione Scientia Limited

Completed

Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea

Rosacea | Papulopustular Rosacea

United States
NHS Lothian
University of Edinburgh

Withdrawn

A Trial of Topical Aloe Vera Gel in Emergency Department Patients Presenting With Simple Traumatic Wounds (ALOE)

Injuries and Wounds

United Kingdom
SIFI SpA

Completed

Safety and Efficacy of Two Different Concentrations (0.5% and 1%) of Progesterone Topical Gel Compared to Placebo in Patients Diagnosed With Moderate to Severe Dry Eye Syndrome (ProGIFT)

Dry Eye Disease

Italy
Integra LifeSciences Corporation
Integrium

Terminated

Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle and With Standard-of-care in Diabetic Foot Ulcers (STRIDE 2)

Diabetic Foot Ulcers

United States, Puerto Rico, Canada, South Africa
Government Dental College and Research Institute...

Completed

Clinical Efficacy of 0.75% Boric Acid Gel in Chronic Periodontitis

Chronic Periodontitis

India
Memorial University of Newfoundland

Recruiting

Biofreeze and the Effect on Knee Osteoarthritis

Knee Osteoarthritis

Canada
October 6 University

Completed

Effect of Ozone Gel on Treatment of Chronic Periodontitis

Periodontal Diseases

Egypt
University Hospital, Bordeaux

Completed

Comparison of Two Type of Laryngeal Mask : I-Gel & LMA ProSeal (I-Gel)

Endotracheal Intubation

France
Bausch Health Americas, Inc.

Completed

Evaluation of Irritation That Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face.

Acne Vulgaris

United States
Cairo University

Recruiting

Effect of Nano-Bio Fusion Gel on Palatal Wound Healing After Free Gingival Graft Harvest.

Free Gingival Graft

Egypt
Dermira, Inc.

Completed

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Acne Vulgaris

United States, Canada, Australia
Topokine Therapeutics, Inc.

Completed

Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers

Lipodystrophy | Lipoatrophy | Nasolabial Folds

United States
Assiut University

Recruiting

Oropharyngeal Leak Pressure Monitoring Using Baska Versus I-gel Laryngeal Mask Airway

Laryngeal Masks

Egypt
Dermira, Inc.

Completed

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Acne Vulgaris

United States, Canada, Australia
Dermira, Inc.

Completed

A Safety, Tolerability and Preliminary Efficacy Study of DRM01B Topical Gel

Acne Vulgaris

Canada
PharmaDax Inc.
Glia, LLC

Enrolling by invitation

Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study

Keratoconjunctivitis Sicca | Dry Eye Syndrome

Taiwan
Mayo Clinic

Not yet recruiting

Sonography of the Nipple Areolar Complex

Healthy

United States
Bausch Health Americas, Inc.

Completed

Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris

Acne Vulgaris

United States, Canada
Loma Linda University

Terminated

Adjunctive Hydrogen Peroxide for Periodontal Therapy (AHP)

Periodontitis, Chronic

United States
Aga Khan University

Completed

Postoperative Sore Throat in Children: Comparison Between Two Supraglottic Devices, Ambu® AuraOnce™ Laryngeal Mask Airway (LMA) and I-Gel®.

Anesthesia | Pharyngitis | Laryngeal Masks | Minors

Pakistan
Northwestern University
Bausch & Lomb Incorporated

Terminated

Comparison of Topical 0.15% Gancyclovir Gel Versus 0.3% Hypromellose Gel for the Treatment of Herpes Zoster Keratitis

Herpes Zoster Keratitis

United States
Goldman, Butterwick, Fitzpatrick and Groff

Completed

TR-987 vs. Placebo Following Fractionated CO2 Laser Resurfacing of the Chest

Exposure Laser

United States
Bezmialem Vakif University

Unknown

The Effect Of I-Gel And Ambu Aura-I Use On Laryngofaryngeal Mucosa

Mucosal Damage

Turkey
Mayo Clinic

Completed

Trendelenburg's Slide Prevention Study (SPS)

Postoperative Complications | Misadventure During Surgical Operation

United States
Swiss Vision Network

Active, not recruiting

Longitudinal Study on Glaucoma Surgery Using XEN® Gel Stent

Glaucoma | Glaucoma, Open-Angle | Glaucoma, Angle-Closure | Glaucoma, Primary Open Angle
University Hospital Inselspital, Berne

Completed

ILMA Fastrach Versus I-gel for Fiberoptic Tracheal Intubation

Tracheal Intubation

Switzerland
LEO Pharma

Completed

A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/Extremities

Actinic Keratosis

Italy
Prism Pharma Co., Ltd.

Completed

Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial

Systemic Scleroderma

United States

3

Subscribe